{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:37:15Z","timestamp":1778528235126,"version":"3.51.4"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s40257-015-0137-5","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T14:49:12Z","timestamp":1436194152000},"page":"389-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Treating Psoriasis During Pregnancy: Safety and Efficacy of Treatments"],"prefix":"10.1007","volume":"16","author":[{"given":"Nannie","family":"Bangsgaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"R\u00f8rbye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone","family":"Skov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,7]]},"reference":[{"issue":"3","key":"137_CR1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0190-9622(85)70188-0","volume":"13","author":"T Henseler","year":"1985","unstructured":"Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13(3):450\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"137_CR2","first-page":"1","volume":"11","author":"G Lomholt","year":"1964","unstructured":"Lomholt G. Prevalence of skin diseases in a population; a census study from the Faroe Islands. Dan Med Bull. 1964;11:1\u20137.","journal-title":"Dan Med Bull"},{"key":"137_CR3","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2133.1997.tb01113.x","volume":"137","author":"DG Fortune","year":"1997","unstructured":"Fortune DG, Main CJ, O\u2019Sullivan TM, Griffiths CEM. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol. 1997;137:755\u201360.","journal-title":"Br J Dermatol"},{"key":"137_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/00015550410023284","volume":"84","author":"R Zachariae","year":"2004","unstructured":"Zachariae R, Zachariae H, Ibsen HHW, Mortensen JT, Wulf HC. Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta Derm Venereol. 2004;84:205\u201312.","journal-title":"Acta Derm Venereol"},{"key":"137_CR5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1087-0024.2003.09110.x","volume":"9","author":"J Korte de","year":"2004","unstructured":"de Korte J, Sprangers MAG, Mombers FMC, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Invest Dermatol Symp Proc. 2004;9:140\u20137.","journal-title":"J Invest Dermatol Symp Proc"},{"key":"137_CR6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","volume":"41","author":"SR Rapp","year":"1999","unstructured":"Rapp SR, Feldman SR, Excum ML, Fleischer AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401\u20136.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"137_CR7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/bjd.12371","volume":"169","author":"C Remr\u00f6d","year":"2013","unstructured":"Remr\u00f6d C, Sj\u00f6str\u00f6m K, Svensson A. Psychological differences between early and late onset psoriasis: a study of personality traits, anxiety and depression in psoriasis. Br J Dermatol. 2013;169(2):344\u201350.","journal-title":"Br J Dermatol"},{"issue":"8","key":"137_CR8","first-page":"891","volume":"146","author":"SK Kurd","year":"2010","unstructured":"Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146(8):891\u20135.","journal-title":"Arch Dermatol"},{"key":"137_CR9","unstructured":"Center for Disease Control and Prevention. Birth defects. 2014. http:\/\/www.cdc.gov\/ncbddd\/birthdefects\/index.html . Accessed 23 June 2015."},{"key":"137_CR10","unstructured":"FDA. Pregnancy and lactation labeling final rule. http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/Labeling\/ucm093307.htm . Accessed 23 June 2015."},{"key":"137_CR11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","volume":"130","author":"S Kagami","year":"2010","unstructured":"Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol. 2010;130:1373\u201383.","journal-title":"J Invest Dermatol"},{"key":"137_CR12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes MA, Su\u00e1rez-Fari\u00f1as M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227\u201355.","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"137_CR13","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/art.38874","volume":"66","author":"AL Rom","year":"2014","unstructured":"Rom AL, Wu CS, Olsen J, Kjaergaard H, Jawaheer D, Hetland ML, et al. Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis: a nationwide cohort study. Arthritis Rheumatol. 2014;66(12):3265\u201373.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"137_CR14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2796.2010.02239.x","volume":"268","author":"M N\u00f8rgaard","year":"2010","unstructured":"N\u00f8rgaard M, Larsson H, Pedersen L, Granath F, Askling J, Kieler H, et al. Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med. 2010;268(4):329\u201337.","journal-title":"J Intern Med"},{"issue":"6","key":"137_CR15","first-page":"1091","volume":"20","author":"G Br\u00f6ms","year":"2014","unstructured":"Br\u00f6ms G, Granath F, Linder M, Stephansson O, Elmberg M, Kieler H. Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure. Inflamm Bowel Dis. 2014;20(6):1091\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"137_CR16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-0030-1249366","volume":"27","author":"Y Sorokin","year":"2010","unstructured":"Sorokin Y, Romero R, Mele L, Wapner RJ, Iams JD, Dudley DJ, et al. Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32\u00a0weeks and adverse neonatal outcomes. Am J Perinatol. 2010;27(8):631\u201340.","journal-title":"Am J Perinatol"},{"issue":"1","key":"137_CR17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/jp.2010.53","volume":"31","author":"G Amarilyo","year":"2011","unstructured":"Amarilyo G, Oren A, Mimouni FB, Ochshorn Y, Deutsch V, Mandel D. Increased cord serum inflammatory markers in small-for-gestational-age neonates. J Perinatol. 2011;31(1):30\u20132.","journal-title":"J Perinatol"},{"issue":"4","key":"137_CR18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/14767058.2010.511340","volume":"24","author":"JA Bastek","year":"2011","unstructured":"Bastek JA, Brown AG, Anton L, Srinivas SK, D\u2019addio A, Elovitz MA. Biomarkers of inflammation and placental dysfunction are associated with subsequent preterm birth. J Matern Fetal Neonatal Med. 2011;24(4):600\u20135.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"137_CR19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/bjd.12355","volume":"169","author":"EA Dowlatshahi","year":"2013","unstructured":"Dowlatshahi EA, van der Voort EA, Arends LR, Nijsten T. Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2013;169(2):266\u201382.","journal-title":"Br J Dermatol"},{"issue":"1","key":"137_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaad.2010.02.005","volume":"64","author":"YW Yang","year":"2011","unstructured":"Yang YW, Chen CS, Chen YH, Lin HC. Psoriasis and pregnancy outcomes: a nationwide population-based study. J Am Acad Dermatol. 2011;64(1):71\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"137_CR21","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1468-3083.2010.03917.x","volume":"25","author":"E Cohen-Barak","year":"2011","unstructured":"Cohen-Barak E, Nachum Z, Rozenman D, Ziv M. Pregnancy outcomes in women with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol. 2011;25(9):1041\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"137_CR22","first-page":"183","volume":"53","author":"G Ben-David","year":"2008","unstructured":"Ben-David G, Sheiner E, Hallak M, Levy A. Pregnancy outcome in women with psoriasis. J Reprod Med. 2008;53(3):183\u20137.","journal-title":"J Reprod Med"},{"issue":"6","key":"137_CR23","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/jid.2014.35","volume":"134","author":"E Harder","year":"2014","unstructured":"Harder E, Andersen AM, Kamper-J\u00f8rgensen M, Skov L. No increased risk of fetal death or prolonged time to pregnancy in women with psoriasis. J Invest Dermatol. 2014;134(6):1747\u20139.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"137_CR24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/jid.2011.271","volume":"132","author":"XT Lima","year":"2012","unstructured":"Lima XT, Janakiraman V, Hughes MD, Kimball AB. The impact of psoriasis on pregnancy outcomes. J Invest Dermatol. 2012;132(1):85\u201391.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"137_CR25","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/jdv.12742","volume":"29","author":"E Edson-Heredia","year":"2015","unstructured":"Edson-Heredia E, Zhu B, Lefevre C, Wang M, Barrett A, Bushe CJ, et al. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink. J Eur Acad Dermatol Venereol. 2015;29(5):955\u201363.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"137_CR26","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.amjmed.2014.08.008","volume":"127","author":"J Shlyankevich","year":"2014","unstructured":"Shlyankevich J, Mehta NN, Krueger JG, Strober B, Gudjonsson JE, Qureshi AA, et al. Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities. Am J Med. 2014;127(12):1148\u201353.","journal-title":"Am J Med"},{"issue":"10","key":"137_CR27","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10067-014-2743-7","volume":"33","author":"M Khraishi","year":"2014","unstructured":"Khraishi M, Aslanov R, Rampakakis E, Pollock C, Sampalis JS. Prevalence of cardiovascular risk factors in patients with psoriatic arthritis. Clin Rheumatol. 2014;33(10):1495\u2013500.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"137_CR28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaad.2013.11.023","volume":"70","author":"MS Lee","year":"2014","unstructured":"Lee MS, Lin RY, Lai MS. Increased risk of diabetes mellitus in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. J Am Acad Dermatol. 2014;70(4):691\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"137_CR29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2133.2010.09899.x","volume":"163","author":"G Bandoli","year":"2010","unstructured":"Bandoli G, Johnson DL, Jones KL, Lopez Jiminez J, Salas E, Mirrasoul N, et al. Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis. Br J Dermatol. 2010;163(2):334\u20139.","journal-title":"Br J Dermatol"},{"key":"137_CR30","unstructured":"Diflorasone diacetate cream [package insert]. Hawthorne: Taro Pharmaceuticals; 1999."},{"issue":"2","key":"137_CR31","first-page":"241","volume":"28","author":"I Narama","year":"1984","unstructured":"Narama I. Reproduction studies of diflorasone diacetate (DDA). IV. Teratogenicity study in rabbits by percutaneous administration. Pharmacometrics. 1984;28(2):241\u201350.","journal-title":"Pharmacometrics"},{"issue":"6","key":"137_CR32","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1597\/02-077","volume":"40","author":"B K\u00e4ll\u00e9n","year":"2003","unstructured":"K\u00e4ll\u00e9n B. Maternal drug use and infant cleft lip\/palate with special reference to corticoids. Cleft Palate Craniofac J. 2003;40(6):624\u20138.","journal-title":"Cleft Palate Craniofac J"},{"issue":"4","key":"137_CR33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ajmg.a.20130","volume":"120A","author":"MJ Edwards","year":"2003","unstructured":"Edwards MJ, Agho K, Attia J, Diaz P, Hayes T, Illingworth A, et al. Case-control study of cleft lip or palate after maternal use of topical corticosteroids during pregnancy. Am J Med Genet A. 2003;120A(4):459\u201363.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"137_CR34","doi-asserted-by":"crossref","first-page":"585. e1\u20137","DOI":"10.1016\/j.ajog.2007.05.046","volume":"197","author":"SL Carmichael","year":"2007","unstructured":"Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ, National Birth Defects Prevention Study. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007;197(6):585. e1\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"137_CR35","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1503\/cmaj.101063","volume":"183","author":"A Hviid","year":"2011","unstructured":"Hviid A, M\u00f8lgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ. 2011;183(7):796\u2013804.","journal-title":"CMAJ"},{"issue":"5","key":"137_CR36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W","volume":"56","author":"AE Czeizel","year":"1997","unstructured":"Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology. 1997;56(5):335\u201340.","journal-title":"Teratology."},{"issue":"12","key":"137_CR37","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/bdra.10134","volume":"67","author":"P Pradat","year":"2003","unstructured":"Pradat P, Robert-Gnansia E, Di Tanna GL, Rosano A, Lisi A. Mastroiacovo P; Contributors to the MADRE database. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol. 2003;67(12):968\u201370.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"3","key":"137_CR38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1034\/j.1600-0412.2002.810308.x","volume":"81","author":"H Mygind","year":"2002","unstructured":"Mygind H, Thulstrup AM, Pedersen L, Larsen H. Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy. Acta Obstet Gynecol Scand. 2002;81(3):234\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"137_CR39","doi-asserted-by":"crossref","unstructured":"Chi CC, Lee CW, Wojnarowska F, Kirtschig G. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev. 2009; 3:CD007346.","DOI":"10.1002\/14651858.CD007346.pub2"},{"issue":"4","key":"137_CR40","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/jid.2010.392","volume":"131","author":"CC Chi","year":"2011","unstructured":"Chi CC, Mayon-White RT, Wojnarowska FT. Safety of topical corticosteroids in pregnancy: a population-based cohort study. J Invest Dermatol. 2011;131(4):884\u201391.","journal-title":"J Invest Dermatol"},{"issue":"11","key":"137_CR41","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jamadermatol.2013.5768","volume":"149","author":"CC Chi","year":"2013","unstructured":"Chi CC, Wang SH, Mayon-White R, Wojnarowska F. Pregnancy outcomes after maternal exposure to topical corticosteroids: a UK population-based cohort study. JAMA Dermatol. 2013;149(11):1274\u201380.","journal-title":"JAMA Dermatol"},{"issue":"Suppl 2","key":"137_CR42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2131\/jts.21.SupplementII_439","volume":"21","author":"H Uchiyama","year":"1996","unstructured":"Uchiyama H, Suzuki T, Koike Y, Ono M, Shirakawa K, Nagata M, et al. Reproductive and developmental toxicity studies of calcipotriol (MC903): (4)\u2014a perinatal and postnatal study in rats by subcutaneous administration. J Toxicol Sci. 1996;21(Suppl 2):439\u201355.","journal-title":"J Toxicol Sci"},{"key":"137_CR43","unstructured":"Center for Drug Evaluation and Research. Application number NDA 22-185. Pharmacology review(s). Taclonex scalp gel. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2008\/022185s000_pharmr.pdf . Accessed 23 June 2015."},{"issue":"6","key":"137_CR44","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0190-9622(97)70067-7","volume":"37","author":"JF Bourke","year":"1997","unstructured":"Bourke JF, Mumford R, Whittaker P, Iqbal SJ, Le Van LW, Trevellyan A, et al. The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis. J Am Acad Dermatol. 1997;37(6):929\u201334.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"137_CR45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00007890-199708270-00002","volume":"64","author":"A Jain","year":"1997","unstructured":"Jain A, Venkataramanan R, Fung JJ, Gartner JC, Lever J, Balan V, et al. Pregnancy after liver transplantation under tacrolimus. Transplantation. 1997;64(4):559\u201365.","journal-title":"Transplantation"},{"issue":"5","key":"137_CR46","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/01.TP.0000084823.89528.89","volume":"76","author":"AB Jain","year":"2003","unstructured":"Jain AB, Reyes J, Marcos A, Mazariegos G, Eghtesad B, Fontes PA, et al. Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center\u2019s experience update at 13 years. Transplantation. 2003;76(5):827\u201332.","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"137_CR47","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1007\/s001470050347","volume":"13","author":"A Kainz","year":"2000","unstructured":"Kainz A, Harabacz I, Cowlrick IS, Gadgil S, Hagiwara D. Analysis of 100 pregnancy outcomes in women treated systemically with tacrolimus. Transpl Int. 2000;13(Suppl 1):S299\u2013300.","journal-title":"Transpl Int"},{"issue":"3","key":"137_CR48","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MJT.0b013e31818a975c","volume":"16","author":"D Pariser","year":"2009","unstructured":"Pariser D. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption. Am J Ther. 2009;16(3):264\u201373.","journal-title":"Am J Ther"},{"key":"137_CR49","unstructured":"Tazarotene [product label]. Medford: Allergan, Inc.; 2014."},{"key":"137_CR50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00003088-199937040-00001","volume":"37","author":"DD-S Tang-Liu","year":"1999","unstructured":"Tang-Liu DD-S, Matsumoto RM, Usansky JI. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment of acne and psoriasis. Clin Pharmacokinet. 1999;37:273\u201387.","journal-title":"Clin Pharmacokinet"},{"issue":"suppl","key":"137_CR51","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1067\/mjd.2000.108321","volume":"43","author":"A Menter","year":"2000","unstructured":"Menter A. Pharmacokinetics and safety of tazarotene. J Am Acad Dermatol. 2000;43(suppl):S31\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"137_CR52","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/jat.2550020509","volume":"2","author":"DL Springer","year":"1982","unstructured":"Springer DL, Poston KA, Mahlum DD, Sikov MR. Teratogenicity following inhalation exposure of rats to a high-boiling coal liquid. J Appl Toxicol. 1982;2(5):260\u20134.","journal-title":"J Appl Toxicol"},{"issue":"2","key":"137_CR53","first-page":"137","volume":"3","author":"RM Santella","year":"1994","unstructured":"Santella RM, Nunes MG, Blaskovic R, Perera FP, Tang D, Beachman A, et al. Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers. Cancer Epidemiol Biomarkers Prev. 1994;3(2):137\u201340.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"137_CR54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00381025","volume":"61","author":"E Clonfero","year":"1989","unstructured":"Clonfero E, Zordan M, Venier P, Paleologo M, Levis AG, Cottica D, et al. Biological monitoring of human exposure to coal tar. Urinary excretion of total polycyclic aromatic hydrocarbons, 1-hydroxypyrene and mutagens in psoriatic patients. Int Arch Occup Environ Health. 1989;61(6):363\u20138.","journal-title":"Int Arch Occup Environ Health"},{"issue":"5","key":"137_CR55","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/000155599750010373","volume":"79","author":"ME Franssen","year":"1999","unstructured":"Franssen ME. A retrospective study of the teratogenicity of dermatological coal tar products. Acta Derm Venereol. 1999;79(5):390\u20131.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"137_CR56","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/01.jom.0000201566.42186.5f","volume":"48","author":"JL Zhu","year":"2006","unstructured":"Zhu JL, Hjollund NH, Andersen AM, Olsen J. Occupational exposure to pesticides and pregnancy outcomes in gardeners and farmers: a study within the Danish National Birth Cohort. J Occup Environ Med. 2006;48(4):347\u201352.","journal-title":"J Occup Environ Med"},{"issue":"1","key":"137_CR57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000114252","volume":"66","author":"WH Tam","year":"2008","unstructured":"Tam WH, Sahota DS, Lau TK, Li CY, Fung TY. Seasonal variation in pre-eclamptic rate and its association with the ambient temperature and humidity in early pregnancy. Gynecol Obstet Invest. 2008;66(1):22\u20136.","journal-title":"Gynecol Obstet Invest"},{"issue":"4","key":"137_CR58","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10103-011-0895-0","volume":"26","author":"LT El-Saie","year":"2011","unstructured":"El-Saie LT, Rabie AR, Kamel MI, Seddeik AK, Elsaie ML. Effect of narrowband ultraviolet B phototherapy on serum folic acid levels in patients with psoriasis. Lasers Med Sci. 2011;26(4):481\u20135.","journal-title":"Lasers Med Sci"},{"issue":"2","key":"137_CR59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jphotobiol.2010.01.013","volume":"101","author":"A Juzeniene","year":"2010","unstructured":"Juzeniene A, Stokke KT, Thune P, Moan J. Pilot study of folate status in healthy volunteers and in patients with psoriasis before and after UV exposure. J Photochem Photobiol B. 2010;101(2):111\u20136.","journal-title":"J Photochem Photobiol B"},{"issue":"2","key":"137_CR60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jaad.2009.03.011","volume":"61","author":"RF Rose","year":"2009","unstructured":"Rose RF, Batchelor RJ, Turner D, Goulden V. Narrowband ultraviolet B phototherapy does not influence serum and red cell folate levels in patients with psoriasis. J Am Acad Dermatol. 2009;61(2):259\u201362.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"137_CR61","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archdermatol.2011.1614","volume":"148","author":"KK Park","year":"2012","unstructured":"Park KK, Murase JE. Narrowband UV-B phototherapy during pregnancy and folic acid depletion. Arch Dermatol. 2012;148(1):132\u20133.","journal-title":"Arch Dermatol"},{"issue":"4","key":"137_CR62","first-page":"285","volume":"20","author":"E Gocke","year":"2001","unstructured":"Gocke E. Photochemical mutagenesis: examples and toxicological relevance J Environ Pathol Toxicol Oncol. 2001;20(4):285\u201392.","journal-title":"Photochemical mutagenesis: examples and toxicological relevance J Environ Pathol Toxicol Oncol"},{"issue":"3","key":"137_CR63","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/archderm.1993.01680240060006","volume":"129","author":"JG Gunnarskog","year":"1993","unstructured":"Gunnarskog JG, Kallen AJ, Lindelof BG, Sigurgeirsson B. Psoralen photochemotherapy (PUVA) and pregnancy. Arch Dermatol. 1993;129(3):320\u20133.","journal-title":"Arch Dermatol"},{"issue":"1","key":"137_CR64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF00292617","volume":"58","author":"A Kistler","year":"1985","unstructured":"Kistler A, Hummler H. Teratogenesis and reproductive safety evaluation of the retinoid etretin (Ro 10-1670). Arch Toxicol. 1985;58(1):50\u20136.","journal-title":"Arch Toxicol"},{"issue":"14","key":"137_CR65","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJM198510033131401","volume":"313","author":"EJ Lammer","year":"1985","unstructured":"Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, et al. Retinoic acid embryopathy. N Engl J Med. 1985;313(14):837\u201341.","journal-title":"N Engl J Med"},{"issue":"10","key":"137_CR66","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/bdra.20078","volume":"70","author":"P Barbero","year":"2004","unstructured":"Barbero P, Lotersztein V, Bronberg R, Perez M, Alba L. Acitretin embryopathy: a case report. Birth Defects Res A Clin Mol Teratol. 2004;70(10):831\u20133.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"4","key":"137_CR67","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/tera.1420520407","volume":"52","author":"CE Die-Smulders de","year":"1995","unstructured":"de Die-Smulders CE, Sturkenboom MC, Veraart J, van Katwijk C, Sastrowijoto P, van der Linden E. Severe limb defects and craniofacial anomalies in a fetus conceived during acitretin therapy. Teratology. 1995;52(4):215\u20139.","journal-title":"Teratology"},{"issue":"1","key":"137_CR68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000018055","volume":"198","author":"H Maradit","year":"1999","unstructured":"Maradit H, Geiger JM. Potential risk of birth defects after acitretin discontinuation. Dermatology. 1999;198(1):3\u20134.","journal-title":"Dermatology"},{"issue":"5","key":"137_CR69","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/1523-1747.ep12472293","volume":"100","author":"FG Larsen","year":"1993","unstructured":"Larsen FG, Jakobsen P, Knudsen J, Weismann K, Kragballe K, Nielsen-Kudsk F. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol. J Invest Dermatol. 1993;100(5):623\u20137.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"137_CR70","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archderm.1989.01670140098019","volume":"125","author":"JJ DiGiovanna","year":"1989","unstructured":"DiGiovanna JJ, Zech LA, Ruddel ME, Gantt G, Peck GL. Etretinate. Persistent serum levels after long-term therapy. Arch Dermatol. 1989;125(2):246\u201351.","journal-title":"Arch Dermatol"},{"issue":"2","key":"137_CR71","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/tera.1420230205","volume":"23","author":"JM DeSesso","year":"1981","unstructured":"DeSesso JM. Comparative ultrastructural alterations in rabbit limb-buds after a teratogenic dose of either hydroxyurea or methotrexate. Teratology. 1981;23(2):197\u2013215.","journal-title":"Teratology"},{"issue":"2","key":"137_CR72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/tera.1420090206","volume":"9","author":"RG Skalko","year":"1974","unstructured":"Skalko RG, Gold MP. Teratogenicity of methotrexate in mice. Teratology. 1974;9(2):159\u201363.","journal-title":"Teratology"},{"issue":"1","key":"137_CR73","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/tera.1420150110","volume":"15","author":"RL Jordan","year":"1977","unstructured":"Jordan RL, Wilson JG, Schumacher HJ. Embryotoxicity of the folate antagonist methotrexate in rats and rabbits. Teratology. 1977;15(1):73\u20139.","journal-title":"Teratology"},{"issue":"2","key":"137_CR74","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/tera.1420490202","volume":"49","author":"AE Donnenfeld","year":"1994","unstructured":"Donnenfeld AE, Pastuszak A, Noah JS, Schick B, Rose NC, Koren G. Methotrexate exposure prior to and during pregnancy. Teratology. 1994;49(2):79\u201381.","journal-title":"Teratology"},{"issue":"5","key":"137_CR75","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.1780400527","volume":"40","author":"LM Buckley","year":"1997","unstructured":"Buckley LM, Bullaboy CA, Leichtman L, Marquez M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum. 1997;40(5):971\u20133.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"137_CR76","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/qjmed\/92.10.551","volume":"92","author":"ME Lloyd","year":"1999","unstructured":"Lloyd ME, Carr M, McElhatton P, Hall GM, Hughes RA. The effects of methotrexate on pregnancy, fertility and lactation. QJM. 1999;92(10):551\u201363.","journal-title":"QJM"},{"issue":"3","key":"137_CR77","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/tera.1420170314","volume":"17","author":"J Warkany","year":"1978","unstructured":"Warkany J. Aminopterin and methotrexate: folic acid deficiency. Teratology. 1978;17(3):353\u20137.","journal-title":"Teratology"},{"issue":"6","key":"137_CR78","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0002-9343(90)90522-F","volume":"88","author":"RD Kozlowski","year":"1990","unstructured":"Kozlowski RD. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med. 1990;88(6):589\u201392.","journal-title":"Am J Med"},{"issue":"4","key":"137_CR79","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0029-7844(01)01607-6","volume":"99","author":"C Nguyen","year":"2002","unstructured":"Nguyen C, Duhl AJ, Escallon CS, Blakemore KJ. Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester. Obstet Gynecol. 2002;99(4):599\u2013602.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"137_CR80","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/S0041-1345(97)00458-2","volume":"29","author":"V Lamarque","year":"1997","unstructured":"Lamarque V, Leleu MF, Monka C, Krupp P. Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun. Transplant Proc. 1997;29(5):2480.","journal-title":"Transplant Proc"},{"issue":"7","key":"137_CR81","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.transproceed.2006.06.020","volume":"38","author":"R Naqvi","year":"2006","unstructured":"Naqvi R, Noor H, Ambareen S, Khan H, Haider A, Jafri N, et al. Outcome of pregnancy in renal allograft recipients: SIUT experience. Transplant Proc. 2006;38(7):2001\u20132.","journal-title":"Transplant Proc"},{"issue":"8","key":"137_CR82","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-200104270-00006","volume":"71","author":"B Bar Oz","year":"2001","unstructured":"Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation. 2001;71(8):1051\u20135.","journal-title":"Transplantation"},{"issue":"7","key":"137_CR83","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0041-1345(00)01469-X","volume":"32","author":"JI Moon","year":"2000","unstructured":"Moon JI, Park SG, Cheon KO, Kim SI, Kim YS, Park YW, et al. Pregnancy in renal transplant patients. Transplant Proc. 2000;32(7):1869\u201370.","journal-title":"Transplant Proc"},{"issue":"2","key":"137_CR84","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejogrb.2004.11.035","volume":"121","author":"ME Ghanem","year":"2005","unstructured":"Ghanem ME, El-Baghdadi LA, Badawy AM, Bakr MA, Sobhe MA, Ghoneim MA. Pregnancy outcome after renal allograft transplantation: 15\u00a0years experience. Eur J Obstet Gynecol Reprod Biol. 2005;121(2):178\u201381.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"137_CR85","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/ndt\/14.6.1511","volume":"14","author":"H Toma","year":"1999","unstructured":"Toma H, Tanabe K, Tokumoto T, Kobayashi C, Yagisawa T. Pregnancy in women receiving renal dialysis or transplantation in Japan: a nationwide survey. Nephrol Dial Transplant. 1999;14(6):1511\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"137_CR86","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0041-1345(98)00408-4","volume":"30","author":"VT Armenti","year":"1998","unstructured":"Armenti VT, McGrory CH, Cater JR, Radomski JS, Moritz MJ. Pregnancy outcomes in female renal transplant recipients. Transplant Proc. 1998;30(5):1732\u20134.","journal-title":"Transplant Proc"},{"issue":"2","key":"137_CR87","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0272-6386(96)90311-X","volume":"28","author":"WJ Gaughan","year":"1996","unstructured":"Gaughan WJ, Moritz MJ, Radomski JS, Burke JF Jr, Armenti VT. National Transplantation Pregnancy Registry: report on outcomes in cyclosporine-treated female kidney transplant recipients with an interval from transplant to pregnancy of greater than five years. Am J Kidney Dis. 1996;28(2):266\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"137_CR88","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2230.2005.01869.x","volume":"30","author":"EV Edmonds","year":"2005","unstructured":"Edmonds EV, Morris SD, Short K, Bewley SJ, Eady RA. Pustular psoriasis of pregnancy treated with ciclosporin and high-dose prednisolone. Clin Exp Dermatol. 2005;30(6):709\u201310.","journal-title":"Clin Exp Dermatol"},{"key":"137_CR89","first-page":"789748","volume":"2010","author":"JD Pole","year":"2010","unstructured":"Pole JD, Mustard CA, To T, et al. Antenatal steroid therapy for fetal lung maturation and the subsequent risk of childhood asthma: a longitudinal analysis. J Pregnancy. 2010;2010:789748.","journal-title":"J Pregnancy"},{"issue":"6","key":"137_CR90","doi-asserted-by":"crossref","first-page":"e005053","DOI":"10.1136\/bmjopen-2014-005053","volume":"4","author":"A Byrjalsen","year":"2014","unstructured":"Byrjalsen A, Fr\u00f8slev T, Tel\u00e9n Andersen AB, Olsen M, S\u00f8rensen HT. Use of corticosteroids during pregnancy and risk of asthma in offspring: a nationwide Danish cohort study. BMJ Open. 2014;4(6):e005053.","journal-title":"BMJ Open"},{"key":"137_CR91","unstructured":"Humira [prescribing information]. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/125057s310lbl.pdf . Accessed 6 May 2015."},{"key":"137_CR92","unstructured":"Remicade\u00ae [prescribing information]. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/103772s5359lbl.pdf . Accessed 6 May 2015."},{"key":"137_CR93","unstructured":"Enbrel\u00ae [prescribing information]. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/103795s5503lbl.pdf . Accessed 6 May 2015."},{"issue":"3","key":"137_CR94","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ajg.2012.430","volume":"108","author":"MJ Casanova","year":"2013","unstructured":"Casanova MJ, Chaparro M, Dom\u00e8nech E, Barreiro-de Acosta M, Bermejo F, Iglesias E, et al. Safety of thiopurines and anti-TNF-\u03b1 drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol. 2013;108(3):433\u201340.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"137_CR95","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1572-0241.2004.30186.x","volume":"99","author":"JA Katz","year":"2004","unstructured":"Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn\u2019s disease and rheumatoid arthritis. Am J Gastroenterol. 2004;99(12):2385\u201392.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"137_CR96","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2010.140822","volume":"70","author":"SM Verstappen","year":"2011","unstructured":"Verstappen SM, King Y, Watson KD, Symmons DP, Hyrich KL, BSRBR Control Centre Consortium, BSR Biologics Register. Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2011;70(5):823\u20136.","journal-title":"Ann Rheum Dis"},{"key":"137_CR97","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reprotox.2013.11.004","volume":"43","author":"O Diav-Citrin","year":"2014","unstructured":"Diav-Citrin O, Otcheretianski-Volodarsky A, Shechtman S, Ornoy A. Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study. Reprod Toxicol. 2014;43:78\u201384.","journal-title":"Reprod Toxicol"},{"issue":"4","key":"137_CR98","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/rheumatology\/kel400","volume":"46","author":"CH Roux","year":"2007","unstructured":"Roux CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford). 2007;46(4):695\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"137_CR99","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/art.22028","volume":"54","author":"KL Hyrich","year":"2006","unstructured":"Hyrich KL, Symmons DP, Watson KD, Silman AJ, British Society for Rheumatology Biologics Register. Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register. Arthritis Rheum. 2006;54(8):2701\u20132.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"137_CR100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jbspin.2008.04.016","volume":"76","author":"JM Berthelot","year":"2009","unstructured":"Berthelot JM, De Bandt M, Goupille P, Solau-Gervais E, Liot\u00e9 F, Goeb V, CRI (Club Rhumatismes et Inflammation), et al. Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature. Joint Bone Spine. 2009;76(1):28\u201334.","journal-title":"Joint Bone Spine"},{"issue":"10","key":"137_CR101","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cgh.2006.07.018","volume":"4","author":"EA Vasiliauskas","year":"2006","unstructured":"Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol. 2006;4(10):1255\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"137_CR102","first-page":"1014","volume":"33","author":"JD Carter","year":"2006","unstructured":"Carter JD, Valeriano J, Vasey FB. Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship. J Rheumatol. 2006;33(5):1014\u20137.","journal-title":"J Rheumatol"},{"issue":"9","key":"137_CR103","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.3899\/jrheum.090141","volume":"36","author":"EE Winger","year":"2009","unstructured":"Winger EE, Reed JL. Was risk properly assessed in Carter, et al\u2019s safety assessment of tumor necrosis factor antagonists during pregnancy? [letter]. J Rheumatol. 2009;36(9):2122.","journal-title":"J Rheumatol"},{"issue":"9","key":"137_CR104","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2036.2011.04617.x","volume":"33","author":"Z Zelinkova","year":"2011","unstructured":"Zelinkova Z, de Haar C, de Ridder L, Pierik MJ, Kuipers EJ, Peppelenbosch MP, van der Woude CJ. High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Aliment Pharmacol Ther. 2011;33(9):1053\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"137_CR105","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1136\/ard.2008.105924","volume":"68","author":"A Murashima","year":"2009","unstructured":"Murashima A, Watanabe N, Ozawa N, Saito H, Yamaguchi K. Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant\u2019s serum. Ann Rheum Dis. 2009;68(11):1793\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"137_CR106","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","volume":"4","author":"K Cheent","year":"2010","unstructured":"Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn\u2019s disease. J Crohns Colitis. 2010;4(5):603\u20135.","journal-title":"J Crohns Colitis"},{"key":"137_CR107","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdrb.20250","volume":"89","author":"PL Martin","year":"2010","unstructured":"Martin PL, Sachs C, Imai N, et al. Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12\/23p40 monoclonal antibody, during pregnancy and lactation. Birth Defects Res B Dev Reprod Toxicol. 2010;89:351\u201363.","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"137_CR108","author":"A Alsenaid","year":"2014","unstructured":"Alsenaid A, Prinz JC. Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis. J Eur Acad Dermatol Venereol. Epub. 2014;. doi: 10.1111\/jdv.12872 .","journal-title":"J Eur Acad Dermatol Venereol. Epub"},{"issue":"3","key":"137_CR109","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ajd.12214","volume":"55","author":"C Sheeran","year":"2014","unstructured":"Sheeran C, Nicolopoulos J. Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester. Australas J Dermatol. 2014;55(3):235\u20136.","journal-title":"Australas J Dermatol"},{"issue":"10","key":"137_CR110","first-page":"1240","volume":"11","author":"R Andrulonis","year":"2012","unstructured":"Andrulonis R, Ferris LK. Treatment of severe psoriasis with ustekinumab during pregnancy. J Drugs Dermatol. 2012;11(10):1240.","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"137_CR111","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jaad.2011.06.011","volume":"66","author":"M Lebwohl","year":"2012","unstructured":"Lebwohl M, Leonardi C, Griffiths CE, Prinz JC, Szapary PO, Yeilding N, et al. Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (part I of II): results from analyses of general safety parameters from pooled phase 2 and 3 clinical trials. J Am Acad Dermatol. 2012;66(5):731\u201341.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"137_CR112","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2011.07.039","volume":"67","author":"YS Bae","year":"2012","unstructured":"Bae YS, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Young M, et al. National Psoriasis Foundation. Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2012;67(3):459\u201377.","journal-title":"J Am Acad Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-015-0137-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-015-0137-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-015-0137-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:28:35Z","timestamp":1559489315000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-015-0137-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,7]]},"references-count":112,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["137"],"URL":"https:\/\/doi.org\/10.1007\/s40257-015-0137-5","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,7]]}}}